Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 09-Jun-2022 titled Press Release issued by ���Olema Pharmaceuticals, Inc (Nasdaq: OLMA)��� announcing an exclusive Collaboration and License Agreement with Aurigene Discovery Technologies Limited, our WOS
Press Release Jun 09 2022
Filed with NSE · · 4 pages · English
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Replay · Oct 23Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings CallRelease
Dr. Reddy's Laboratories Ltd. on 6ix
Earlier from Dr. Reddy's Laboratories
- Press Release May 27 2022
- Press Release May 24 2022
- Press Release May 11 2022
- Press Release Apr 20 2022
- Press Release Apr 05 2022
Later from Dr. Reddy's Laboratories
- Press Release Jun 14 2022
- Dr. Reddy's Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma
- Press Release Jun 24 2022
- Press Release Jun 28 2022
- Press Release Jul 08 2022
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories